# Gemini Pharmaceuticals, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f

> Inspection records and compliance data for Gemini Pharmaceuticals, Inc. in Commack, New York. Access full analysis and detailed observations.

---

## Details

- Name: Gemini Pharmaceuticals, Inc.
- FEI Number: 2432926
- City: Commack
- State: New York
- Country Name: United States
- Address Line 1: 87 Modular Ave
- Zip Code: 11725

## Related Documents

- [483 - Gemini Pharmaceuticals, Inc. - 2022-07-26](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/ece92446-1406-489e-aeac-8758665dd9f7) — source: FDA, date: July 26, 2022
- [FDA Inspection 1175407 - Gemini Pharmaceuticals, Inc. - 2022-07-26](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/92c472bb-08e5-409c-b8ae-8486b86edb42) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2022
- [FDA Inspection 1175407 - Gemini Pharmaceuticals, Inc. - 2022-07-26](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/e65a779b-d253-4945-bbc8-dfca238ee96d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2022
- [FDA Inspection 1064447 - Gemini Pharmaceuticals, Inc. - 2018-08-23](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/75b14ea2-9725-4534-814a-36758a020bba) — classification: No Action Indicated (NAI), source: FDA, date: August 23, 2018
- [483 - Gemini Pharmaceuticals, Inc. - 2018-02-16](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/563a968e-94b3-45dd-b4f5-b8039e638982) — source: FDA, date: February 16, 2018
- [FDA Inspection 1041525 - Gemini Pharmaceuticals, Inc. - 2018-02-16](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/5f815dde-5720-44ae-a6e5-ab350f64a85e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2018
- [483 - Gemini Pharmaceuticals, Inc. - 2015-06-30](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/355d3e31-f50a-4ffb-8c27-5cb4b6411eb3) — source: FDA, date: June 30, 2015
- [FDA Inspection 936886 - Gemini Pharmaceuticals, Inc. - 2015-06-30](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/6d577591-8391-4524-a2b4-21427df5636b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2015
- [FDA Inspection 856101 - Gemini Pharmaceuticals, Inc. - 2013-11-08](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/755ecb80-8106-43f2-8f2c-49f8a092e6ac) — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2013
- [FDA Inspection 856101 - Gemini Pharmaceuticals, Inc. - 2013-11-08](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/a0e9984c-d1de-458a-8f0d-9838d2949911) — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2013
- [FDA Inspection 804876 - Gemini Pharmaceuticals, Inc. - 2012-09-07](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/8ccd38c4-b04f-4a2f-a1ab-040379671397) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2012
- [483 - Gemini Pharmaceuticals, Inc. - 2011-06-01](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/d3335f63-f681-4529-a490-7f5be013903e) — source: FDA, date: June 1, 2011
- [FDA Inspection 726235 - Gemini Pharmaceuticals, Inc. - 2011-06-01](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/36e1597c-1447-4a34-be98-ec5dcbc2deb5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2011
- [FDA Inspection 652318 - Gemini Pharmaceuticals, Inc. - 2010-03-23](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/0dd8aacb-038a-4c9f-8703-2e76055dd836) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 23, 2010

## Related Companies

- [Greer Laboratories, Inc.](https://www.keypedia.com/companies/greer-laboratories-inc/9e93bfa2-3578-44bb-93cd-fa80496d73a5)
- [Syntho Pharmaceuticals, Inc.](https://www.keypedia.com/companies/syntho-pharmaceuticals-inc/911b39ba-d7b3-4ac6-8d51-70ea7dd68454)
- [Sanitor Corporation](https://www.keypedia.com/companies/sanitor-corporation/99144124-9868-4094-bfdf-73d3aa7edf40)
- [GC America, Inc.](https://www.keypedia.com/companies/gc-america-inc/ef0ee3f7-2cac-4212-8512-b78c9d54b20d)
- [SUCO, Inc.](https://www.keypedia.com/companies/suco-inc/72353a3f-ae10-40e9-a987-e16d075d9122)
- [Hisamitsu Pharmaceutical Co., Inc.](https://www.keypedia.com/companies/hisamitsu-pharmaceutical-co-inc/86a5b8bc-8a98-4ed8-a8b6-895f8012b1cb)
- [ChiRhoClin, Inc](https://www.keypedia.com/companies/chirhoclin-inc/a63ad8fd-139c-40ea-bc63-d690e9b58437)
- [Church & Dwight Co., Inc.](https://www.keypedia.com/companies/church-dwight-co-inc/d49e7802-d435-46ac-a95b-029bb35bff98)
- [Speciality Pharma Manufacturing, LLC](https://www.keypedia.com/companies/speciality-pharma-manufacturing-llc/afeaf00e-9366-48fe-a7f1-65891c3588d0)
- [Medispray Laboratories Private Limited](https://www.keypedia.com/companies/medispray-laboratories-private-limited/1633b4c0-6776-4222-af67-4cd6c51eba87)

## Related Officers

- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [investigator](https://www.keypedia.com/people/deborah-j-parris/0763ef7f-992d-412b-8497-4539ed851c03)
- [Game-Changer, Strategic Collaborator and Global Innovator](https://www.keypedia.com/people/charisse-k-green/b5f69339-e0db-42b8-90b3-081a01fe63f3)
- [investigator](https://www.keypedia.com/people/christopher-s-fields/066519e8-20eb-4c41-aaf6-5b17348a0409)
- [investigator](https://www.keypedia.com/people/jose-o-hernandez/960bffbe-1b8e-41bc-b203-aee88d7d8dac)